Stock ISAB INHALATION SCIENCES SWEDEN AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Inhalation Sciences Sweden AB

Equities

ISAB

SE0009983893

Advanced Medical Equipment & Technology

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 06:00:00 2024-01-30 pm EST 		5-day change 1st Jan Change
4.34 SEK +6.90% Intraday chart for Inhalation Sciences Sweden AB -.--% +7.43%
Feb. 28 Inhalation Sciences Sweden AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Feb. 28 Inhalation Sciences Sweden AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Capitalization 1 99.74 116 55.29 61.28 65.83 -
Enterprise Value (EV) 1 99.74 103.5 55.29 61.28 55.53 65.83
P/E ratio 10.1 x -6.99 x -4.54 x - - -
Yield - - - - - -
Capitalization / Revenue - 12.3 x - 3.5 x 1.72 x 1 x
EV / Revenue - 11 x - 3.5 x 1.45 x 1 x
EV / EBITDA - -6,723,394 x - -23,219,876 x - -
EV / FCF - -5,477,504 x - - - -
FCF Yield - -0% - - - -
Price to Book - 5.9 x - - - -
Nbr of stocks (in thousands) 8,635 11,376 11,376 15,168 15,168 -
Reference price 2 11.55 10.20 4.860 4.040 4.340 4.340
Announcement Date 2/25/21 2/28/22 2/28/23 4/11/24 - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Net sales 1 - 9.422 - 17.5 38.3 65.8
EBITDA - -15.39 - -2.639 - -
EBIT 1 - -16.57 - -3.756 8.2 10.1
Operating Margin - -175.88% - -21.46% 21.41% 15.35%
Earnings before Tax (EBT) - -16.61 - -4.744 - -
Net income 9.875 -16.61 -12.12 -4.744 - -
Net margin - -176.28% - -27.1% - -
EPS 1.140 -1.460 -1.070 - - -
Free Cash Flow - -18.89 - - - -
FCF margin - -200.52% - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 2/25/21 2/28/22 2/28/23 4/11/24 - -
1SEK in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 3.238 5.788 3.361 4.842 7.7 10 8.4 12.3
EBITDA - - - - - - - -
EBIT 1 -2.098 -0.107 -0.984 -0.749 1.1 2.3 1.1 3.6
Operating Margin -64.79% -1.85% -29.28% -15.47% 14.29% 23% 13.1% 29.27%
Earnings before Tax (EBT) - - - - - - - -
Net income - - - - - - - -
Net margin - - - - - - - -
EPS - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 5/31/23 8/29/23 11/22/23 4/11/24 - - - -
1SEK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Net Debt 1 - - - - - -
Net Cash position 1 - 12.5 - - 10.3 -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - -18.9 - - - -
ROE (net income / shareholders' equity) - -110% - - - -
ROA (Net income/ Total Assets) - - - - - -
Assets - - - - - -
Book Value Per Share - 1.730 - - - -
Cash Flow per Share - - - - - -
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 2/25/21 2/28/22 2/28/23 4/11/24 - -
1SEK in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
INHALATION SCIENCES SWEDEN AB Stock Inhalation Sciences Sweden AB
+7.43% 6M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.07% 219B
DANAHER CORPORATION Stock Danaher Corporation
+6.59% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+11.26% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+26.57% 108B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+2.47% 63.06B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.35% 52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-0.62% 48.2B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-0.93% 40.37B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+11.54% 39.35B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. ISAB Stock
  4. Financials Inhalation Sciences Sweden AB